25 related articles for article (PubMed ID: 2954268)
1. NUDT15 polymorphism and NT5C2 and PRPS1 mutations influence thiopurine sensitivity in acute lymphoblastic leukaemia cells.
Somazu S; Tanaka Y; Tamai M; Watanabe A; Kagami K; Abe M; Harama D; Shinohara T; Akahane K; Goi K; Sugita K; Moriyama T; Yang J; Goto H; Minegishi M; Iwamoto S; Takita J; Inukai T
J Cell Mol Med; 2021 Nov; 25(22):10521-10533. PubMed ID: 34636169
[TBL] [Abstract][Full Text] [Related]
2. Inherited genetic variants associated with glucocorticoid sensitivity in leukaemia cells.
Shinohara T; Urayama KY; Watanabe A; Akahane K; Goi K; Huang M; Kagami K; Abe M; Sugita K; Okada Y; Goto H; Minegishi M; Iwamoto S; Inukai T
J Cell Mol Med; 2020 Nov; 24(22):12920-12932. PubMed ID: 33002292
[TBL] [Abstract][Full Text] [Related]
3. Copy number abnormality of acute lymphoblastic leukemia cell lines based on their genetic subtypes.
Tomoyasu C; Imamura T; Tomii T; Yano M; Asai D; Goto H; Shimada A; Sanada M; Iwamoto S; Takita J; Minegishi M; Inukai T; Sugita K; Hosoi H
Int J Hematol; 2018 Sep; 108(3):312-318. PubMed ID: 29786757
[TBL] [Abstract][Full Text] [Related]
4. Clofarabine exerts antileukemic activity against cytarabine-resistant B-cell precursor acute lymphoblastic leukemia with low deoxycytidine kinase expression.
Huang M; Inukai T; Miyake K; Tanaka Y; Kagami K; Abe M; Goto H; Minegishi M; Iwamoto S; Sugihara E; Watanabe A; Somazu S; Shinohara T; Oshiro H; Akahane K; Goi K; Sugita K
Cancer Med; 2018 Apr; 7(4):1297-1316. PubMed ID: 29473342
[TBL] [Abstract][Full Text] [Related]
5. Anti-leukemic activity of bortezomib and carfilzomib on B-cell precursor ALL cell lines.
Takahashi K; Inukai T; Imamura T; Yano M; Tomoyasu C; Lucas DM; Nemoto A; Sato H; Huang M; Abe M; Kagami K; Shinohara T; Watanabe A; Somazu S; Oshiro H; Akahane K; Goi K; Kikuchi J; Furukawa Y; Goto H; Minegishi M; Iwamoto S; Sugita K
PLoS One; 2017; 12(12):e0188680. PubMed ID: 29236701
[TBL] [Abstract][Full Text] [Related]
6. Lymphocyte transformation induced by autologous cells.
Weksler ME; Kuntz MM; Birnbaum G; Innes JB
Fed Proc; 1978 Aug; 37(10):2370-3. PubMed ID: 79505
[TBL] [Abstract][Full Text] [Related]
7. Immunologic and clinicopathologic features of common acute lymphoblastic leukemia antigen-positive childhood T-cell leukemia. A Pediatric Oncology Group Study.
Dowell BL; Borowitz MJ; Boyett JM; Pullen DJ; Crist WM; Quddus FF; Russell EC; Falletta JM; Metzgar RS
Cancer; 1987 Jun; 59(12):2020-6. PubMed ID: 2952260
[TBL] [Abstract][Full Text] [Related]
8. Establishment of a common acute lymphoblastic leukemia cell line (LC4-1) and effects of phorbol myristate acetate (PMA) on the surface antigen expression of the cell line.
Yoshimura T; Mayumi M; Yorifuji T; Kim KM; Heike T; Miyanomae T; Shinomiya K; Mikawa H
Am J Hematol; 1987 Sep; 26(1):47-54. PubMed ID: 3115091
[TBL] [Abstract][Full Text] [Related]
9. Induction of human B cell antigens in non-T cell acute lymphoblastic leukemia.
Nadler LM; Ritz J; Bates MP; Park EK; Anderson KC; Sallan SE; Schlossman SF
J Clin Invest; 1982 Aug; 70(2):433-42. PubMed ID: 6980230
[TBL] [Abstract][Full Text] [Related]
10. B4, a human B lymphocyte-associated antigen expressed on normal, mitogen-activated, and malignant B lymphocytes.
Nadler LM; Anderson KC; Marti G; Bates M; Park E; Daley JF; Schlossman SF
J Immunol; 1983 Jul; 131(1):244-50. PubMed ID: 6408173
[TBL] [Abstract][Full Text] [Related]
11. Characterization of new non-T, non-B acute lymphoblastic leukemia cell lines: analysis of surface antigens by quantitative cellular radioimmunoassay and flow cytometry.
Okamura J; Okano H; Ikuno Y; Tasaka H; Motomura S; Letarte M; Gelfand EW
Leuk Res; 1984; 8(1):97-104. PubMed ID: 6230491
[TBL] [Abstract][Full Text] [Related]
12. Establishment of five human malignant non-T lymphoid cell lines and mixed lymphocyte-tumor reaction.
Minegishi M; Tsuchiya S; Minegishi N; Konno T
Tohoku J Exp Med; 1987 Mar; 151(3):283-92. PubMed ID: 2954268
[TBL] [Abstract][Full Text] [Related]
13. The use of monoclonal antibodies for purging autologous bone marrow in the lymphoid malignancies.
Macintyre EA
Clin Haematol; 1986 Feb; 15(1):249-67. PubMed ID: 3516492
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
